Income Statement Unilever PLC

Stocks

ULVR

GB00BVZK7T90

Personal Products

Market Closed - London S.E. Other stock markets 11:35:03 2026-06-12 EDT			5-day change	1st Jan Change
4,386.00 ^GBX	+0.78%		+4.72%	-9.74%

06-11	Citi hires Ryan Beaupré as MD in consumer and retail investment banking push	RE
06-11	European Equities Traded in US as ADRs Rise in Thursday Trading	MT

e2eb98568.SE_VRAPEv0UtTcL-hc4b7mvcxF1YI8IJ5YnweFpoAXc.IXmGclr95y5_HvK8y_1cpyyKjm4NQKNPtb-eEBEHRxYJO59yb66JLh4A8g

Published financial data: UNILEVER PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	52.44B	60.07B	59.6B	60.76B	50.5B
Total Revenues	52.44B	60.07B	59.6B	60.76B	50.5B
Cost of Goods Sold, Total	30.26B	35.91B	34.43B	33.39B	26.79B
Gross Profit	22.18B	24.17B	25.18B	27.37B	23.71B
Selling General & Admin Expenses, Total	11.71B	13.53B	15.13B	16.12B	13.5B
R&D Expenses	847M	908M	-	-	-
Other Operating Expenses	-11M	2M	-27M	3M	81M
Other Operating Expenses, Total	12.55B	14.44B	15.11B	16.12B	13.58B
Operating Income	9.64B	9.72B	10.07B	11.25B	10.13B
Interest Expense, Total	-489M	-769M	-1.08B	-1.12B	-1.1B
Interest And Investment Income	238M	305M	442M	451M	398M
Net Interest Expenses	-251M	-464M	-633M	-667M	-700M
Income (Loss) On Equity Invest.	191M	208M	231M	255M	245M
Currency Exchange Gains (Loss)	7M	-29M	37M	5M	74M
Other Non Operating Income (Expenses)	-9M	-20M	-	-	-1M
EBT, Excl. Unusual Items	9.58B	9.42B	9.7B	10.84B	9.74B
Restructuring Charges	-632M	-777M	-499M	-850M	-599M
Merger & Related Restructuring Charges	-136M	-8M	-242M	-387M	-288M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-22M	-	-17M
Gain (Loss) On Sale Of Assets	-160M	2.29B	489M	-406M	-36M
Asset Writedown	-17M	-263M	-1M	-133M	-43M
Legal Settlements	-	-82M	107M	-	-
Other Unusual Items	-74M	-246M	-196M	-195M	-68M
EBT, Incl. Unusual Items	8.56B	10.34B	9.34B	8.87B	8.69B
Income Tax Expense	1.94B	2.07B	2.2B	2.5B	2.48B
Earnings From Continuing Operations	6.62B	8.27B	7.14B	6.37B	6.21B
Earnings Of Discontinued Operations	-	-	-	-	3.79B
Net Income to Company	6.62B	8.27B	7.14B	6.37B	10B
Minority Interest	-572M	-627M	-653M	-625M	-531M
Net Income - (IS)	6.05B	7.64B	6.49B	5.74B	9.47B
Net Income to Common Incl Extra Items	6.05B	7.64B	6.49B	5.74B	9.47B
Net Income to Common Excl. Extra Items	6.05B	7.64B	6.49B	5.74B	5.68B
Per Share Items
Net EPS - Basic	2.94	3.8	3.26	2.92	4.34
Basic EPS - Continuing Operations	2.94	3.8	3.26	2.92	2.6
Basic Weighted Average Shares Outstanding	2.05B	2.01B	1.99B	1.97B	2.18B
Net EPS - Diluted	2.94	3.78	3.24	2.9	4.32
Diluted EPS - Continuing Operations	2.94	3.78	3.24	2.9	2.59
Diluted Weighted Average Shares Outstanding	2.06B	2.02B	2B	1.98B	2.2B
Normalized Basic EPS	2.63	2.61	2.72	3.12	2.55
Normalized Diluted EPS	2.62	2.6	2.7	3.1	2.53
Dividend Per Share	1.96	1.87	1.92	2.01	1.98
Payout Ratio	74.11	56.65	67.26	75.19	47.03
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	10.73B	11.02B	11.06B	12.28B	10.85B
EBITA	9.69B	9.96B	10.11B	11.28B	10.16B
EBIT	9.64B	9.72B	10.07B	11.25B	10.13B
EBITDAR	10.88B	11.18B	11.23B	12.45B	11B
Effective Tax Rate - (Ratio)	22.62	20.01	23.55	28.19	28.54
Total Current Taxes	2.15B	2.27B	2.25B	2.65B	3.35B
Total Deferred Taxes	-219M	-199M	-53M	-153M	-873M
Normalized Net Income	5.41B	5.26B	5.41B	6.15B	5.56B
Interest on Long-Term Debt	72M	72M	72M	77M	79M
Non-Cash Pension Expense	-7M	-46M	-112M	-140M	-179M
Supplemental Operating Expense Items
Marketing Expenses	6.87B	7.82B	8.55B	9.41B	8.14B
Selling and Marketing Expenses	6.87B	7.82B	8.55B	9.41B	8.14B
Research And Development Expense From Footnotes	847M	908M	949M	987M	836M
Net Rental Expense, Total	151M	167M	170M	168M	150M
Imputed Operating Lease Interest Expense	20.57M	34.46M	49.47M	48.73M	43.68M
Imputed Operating Lease Depreciation	130M	133M	121M	119M	106M
Stock-Based Comp., Other (Total)	161M	177M	212M	324M	255M
Total Stock-Based Compensation	161M	177M	212M	324M	255M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	3.42B	4.33B	4.16B	6.14B	3.94B
Short Term Investments	751M	772M	1.11B	1.05B	541M
Trading Asset Securities, Total	340M	500M	582M	446M	530M
Total Cash And Short Term Investments	4.51B	5.6B	5.85B	7.63B	5.01B
Accounts Receivable, Total	3.58B	4.54B	4.02B	4.61B	4.85B
Other Receivables	922M	1.13B	1.01B	955M	892M
Notes Receivable	-	-	-	-	-
Total Receivables	4.5B	5.68B	5.03B	5.57B	5.74B
Inventory	4.68B	5.93B	5.12B	5.18B	4.04B
Prepaid Expenses	492M	969M	516M	506M	1.37B
Other Current Assets, Total	3.22B	981M	1.38B	315M	898M
Total Current Assets	17.4B	19.16B	17.9B	19.19B	17.07B
Gross Property Plant And Equipment	22.06B	23.12B	22.84B	24.2B	18.1B
Accumulated Depreciation	-11.71B	-12.35B	-12.13B	-12.53B	-9.11B
Net Property Plant And Equipment	10.35B	10.77B	10.71B	11.67B	8.99B
Long-term Investments	1.06B	1B	1.22B	1.44B	2.98B
Goodwill	20.33B	21.61B	21.11B	22.31B	17.71B
Other Intangibles, Total	18.26B	18.88B	18.36B	18.59B	17.06B
Accounts Receivable Long-Term	499M	520M	394M	344M	302M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	1.46B	1.05B	1.11B	1.28B	1.15B
Other Long-Term Assets, Total	5.73B	4.84B	4.46B	4.92B	5.22B
Total Assets	75.1B	77.82B	75.27B	79.75B	70.47B
Liabilities
Accounts Payable, Total	8.9B	11.1B	10.36B	10.26B	10.99B
Accrued Expenses, Total	4.88B	5.86B	5.57B	5.61B	5.21B
Short-term Borrowings	4.03B	2.16B	1.58B	2.34B	65M
Current Portion of Long-Term Debt	2.85B	3.28B	3.17B	4.33B	2.24B
Current Portion of Leases	365M	340M	334M	322M	277M
Current Income Taxes Payable	1.36B	877M	851M	678M	1.44B
Other Current Liabilities	2.39B	1.82B	1.64B	1.7B	1.43B
Total Current Liabilities	24.78B	25.43B	23.51B	25.23B	21.66B
Long-Term Debt	21.6B	22.64B	23.47B	23.9B	24.65B
Long-Term Leases	1.28B	1.07B	1.06B	1.16B	1.05B
Pension & Other Post Retirement Benefits	2.13B	1.69B	1.38B	1.19B	944M
Deferred Tax Liability Non Current	4.53B	4.38B	4B	4.34B	3.6B
Other Non Current Liabilities	1.03B	914M	1.08B	1.36B	979M
Total Liabilities	55.35B	56.12B	54.5B	57.2B	52.88B
Common Stock, Total	92M	92M	88M	88M	85M
Additional Paid In Capital	52.84B	52.84B	52.84B	52.84B	52.84B
Retained Earnings	46.74B	50.25B	47.05B	49.72B	44.23B
Treasury Stock	-3.41B	-4.81B	-6.24B	-2.3B	-3.8B
Comprehensive Income and Other	-79.17B	-79.36B	-75.64B	-80.37B	-77.82B
Total Common Equity	17.11B	19.02B	18.1B	19.99B	15.53B
Minority Interest	2.64B	2.68B	2.66B	2.56B	2.06B
Total Equity	19.75B	21.7B	20.76B	22.56B	17.59B
Total Liabilities And Equity	75.1B	77.82B	75.27B	79.75B	70.47B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.28B	2.25B	2.22B	2.2B	2.18B
ECS Total Common Shares Outstanding	2.28B	2.25B	2.22B	2.2B	2.18B
Book Value / Share	7.51	8.46	8.15	9.08	7.13
Tangible Book Value	-21.48B	-21.47B	-21.36B	-20.91B	-19.23B
Tangible Book Value Per Share	-9.43	-9.55	-9.62	-9.5	-8.83
Total Debt	30.13B	29.49B	29.62B	32.05B	28.28B
Net Debt	25.63B	23.89B	23.77B	24.42B	23.27B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-3.42B	-2.93B	-2.74B	-3.31B	-3.8B
Debt Equivalent Oper. Leases	1.21B	1.34B	1.36B	1.34B	1.2B
Minority Interest, Total (Incl. Fin. Div)	2.64B	2.68B	2.66B	2.56B	2.06B
Equity Method Investments, Total	60M	84M	94M	94M	109M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	1.6B	2.06B	1.82B	1.91B	1.57B
Inventories - Finished Goods, Total	3.39B	4.25B	3.66B	3.57B	2.69B
Land - (BS)	380M	504M	471M	556M	496M
Buildings, Total	3.89B	4.1B	4.01B	4.31B	3.13B
Machinery, Total	14.46B	14.15B	13.9B	14.43B	10.09B
Full Time Employees	148K	127K	128K	116K	93.73K
Part Time Employees	-	-	-	-	2
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	201M	188M	198M	179M	165M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	6.05B	7.64B	6.49B	5.74B	9.47B
Depreciation & Amortization - CF	1.47B	1.49B	1.35B	1.38B	1.06B
Amortization of Goodwill and Intangible Assets - (CF)	52M	239M	41M	35M	34M
Depreciation & Amortization, Total	1.52B	1.73B	1.39B	1.41B	1.09B
Amortization of Deferred Charges, Total - (CF)	222M	216M	187M	213M	222M
(Gain) Loss From Sale Of Asset	23M	-2.34B	-433M	436M	58M
Asset Writedown & Restructuring Costs	17M	-	1M	133M	42M
(Income) Loss On Equity Investments - (CF)	-282M	-232M	-209M	-268M	-228M
Stock-Based Compensation (CF)	161M	177M	212M	324M	255M
Net Cash From Discontinued Operations	-	-	-	-	298M
Other Operating Activities, Total	305M	506M	976M	1.69B	-2.97B
Change In Accounts Receivable	-307M	-1.85B	768M	-206M	-2.62B
Change In Inventories	-458M	-1.4B	340M	-198M	-281M
Change In Accounts Payable	718M	2.83B	-294M	244M	3.02B
Cash from Operations	7.97B	7.28B	9.43B	9.52B	8.35B
Capital Expenditure	-1.11B	-1.46B	-1.5B	-1.74B	-1.42B
Sale of Property, Plant, and Equipment	101M	82M	42M	37M	126M
Cash Acquisitions	-2.13B	-979M	-704M	-795M	-1.67B
Divestitures	43M	4.62B	436M	985M	107M
Sale (Purchase) of Intangible assets	-232M	-253M	-243M	-233M	-174M
Investment in Marketable and Equity Securities, Total	-252M	-35M	-829M	426M	43M
Other Investing Activities, Total	333M	472M	506M	693M	-129M
Cash from Investing	-3.25B	2.45B	-2.29B	-625M	-3.12B
Short Term Debt Issued, Total	656M	-	-	643M	-
Long-Term Debt Issued, Total	4.75B	7.78B	4.97B	4.74B	4.28B
Total Debt Issued	5.4B	7.78B	4.97B	5.38B	4.28B
Short Term Debt Repaid, Total	-	-545M	-570M	-	-2.23B
Long-Term Debt Repaid, Total	-4.01B	-8.96B	-4.3B	-4.69B	-3.85B
Total Debt Repaid	-4.01B	-9.5B	-4.87B	-4.69B	-6.08B
Repurchase of Common Stock	-3.02B	-1.51B	-1.51B	-1.51B	-1.51B
Common Dividends Paid	-4.48B	-4.33B	-4.36B	-4.32B	-4.45B
Common & Preferred Stock Dividends Paid	-4.48B	-4.33B	-4.36B	-4.32B	-4.45B
Other Financing Activities, Total	-988M	-1.32B	-1.43B	-1.81B	947M
Cash from Financing	-7.1B	-8.89B	-7.19B	-6.94B	-6.81B
Foreign Exchange Rate Adjustments	285M	-7M	-119M	-48M	-498M
Net Change in Cash	-2.09B	838M	-180M	1.9B	-2.08B
Supplemental Items
Cash Interest Paid	488M	744M	899M	1.08B	1.02B
Cash Income Tax Paid (Refund)	2.33B	2.81B	2.14B	2.62B	2.72B
Levered Free Cash Flow	4.64B	7.47B	5.94B	6.36B	6.27B
Unlevered Free Cash Flow	4.95B	7.95B	6.62B	7.06B	6.96B
Change In Net Working Capital	1.64B	-1.46B	-278M	-56M	-655M
Net Debt Issued / Repaid	1.39B	-1.73B	103M	697M	-1.8B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.44	7.95	8.22	9.07	8.43
Return on Total Capital	12.7	12.03	12.39	13.39	12.6
Return On Equity %	35.41	39.9	33.63	29.41	30.96
Return on Common Equity	37.37	42.31	34.95	30.16	31.99
Margin Analysis
Gross Profit Margin %	42.3	40.23	42.24	45.05	46.95
SG&A Margin	22.33	22.53	25.39	26.53	26.73
EBITDA Margin %	20.46	18.34	18.55	20.21	21.48
EBITA Margin %	18.47	16.59	16.96	18.57	20.12
EBIT Margin %	18.38	16.19	16.89	18.51	20.05
Income From Continuing Operations Margin %	12.62	13.76	11.98	10.48	12.3
Net Income Margin %	11.53	12.72	10.88	9.45	18.75
Net Avail. For Common Margin %	11.53	12.72	10.88	9.45	11.25
Normalized Net Income Margin	10.32	8.76	9.08	10.12	11.01
Levered Free Cash Flow Margin	8.85	12.44	9.97	10.47	12.42
Unlevered Free Cash Flow Margin	9.43	13.24	11.1	11.62	13.78
Asset Turnover
Asset Turnover	0.73	0.79	0.78	0.78	0.67
Fixed Assets Turnover	5.02	5.69	5.55	5.43	4.89
Receivables Turnover (Average Receivables)	14.95	14.79	13.91	13.45	11.13
Inventory Turnover (Average Inventory)	6.62	6.77	6.23	6.49	5.81
Short Term Liquidity
Current Ratio	0.7	0.75	0.76	0.76	0.79
Quick Ratio	0.36	0.44	0.46	0.52	0.5
Operating Cash Flow to Current Liabilities	0.32	0.29	0.4	0.38	0.39
Days Sales Outstanding (Average Receivables)	24.41	24.69	26.23	27.21	32.81
Days Outstanding Inventory (Average Inventory)	55.16	53.95	58.57	56.43	62.8
Average Days Payable Outstanding	103.41	98.22	116.47	112.77	151.15
Cash Conversion Cycle (Average Days)	-23.84	-19.59	-31.67	-29.14	-55.54
Long Term Solvency
Total Debt/Equity	152.6	135.88	142.66	142.11	160.79
Total Debt / Total Capital	60.41	57.61	58.79	58.7	61.65
LT Debt/Equity	115.88	109.27	118.16	111.13	146.11
Long-Term Debt / Total Capital	45.87	46.32	48.69	45.9	56.03
Total Liabilities / Total Assets	73.71	72.11	72.41	71.72	75.04
EBIT / Interest Expense	19.71	12.65	9.37	10.06	9.22
EBITDA / Interest Expense	22.82	14.9	10.66	11.32	10.21
(EBITDA - Capex) / Interest Expense	20.56	13	9.26	9.77	8.92
Total Debt / EBITDA	2.7	2.57	2.59	2.53	2.52
Net Debt / EBITDA	2.3	2.09	2.07	1.93	2.07
Total Debt / (EBITDA - Capex)	3	2.95	2.97	2.94	2.89
Net Debt / (EBITDA - Capex)	2.55	2.39	2.39	2.24	2.37
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.39	14.55	-0.78	1.94	-3.77
Gross Profit, 1 Yr. Growth %	0.66	8.93	4.17	8.72	-3.24
EBITDA, 1 Yr. Growth %	0.86	2.48	3.3	10.54	-0.75
EBITA, 1 Yr. Growth %	2.94	2.84	2.37	11.03	-1.47
EBIT, 1 Yr. Growth %	2.98	0.91	4.48	11.14	-1.47
Earnings From Cont. Operations, 1 Yr. Growth %	9.02	24.89	-13.65	-10.8	2.88
Net Income, 1 Yr. Growth %	8.39	26.33	-15.11	-11.45	64.85
Normalized Net Income, 1 Yr. Growth %	4.93	-2.81	3.97	12.97	-0.76
Diluted EPS Before Extra, 1 Yr. Growth %	9.44	28.88	-14.38	-10.55	6.15
Accounts Receivable, 1 Yr. Growth %	4.34	26.86	-11.47	4.27	14.79
Inventory, 1 Yr. Growth %	4.95	26.65	-13.69	1.13	-21.9
Net Property, Plant and Equip., 1 Yr. Growth %	-2	4.09	-0.58	8.98	-22.94
Total Assets, 1 Yr. Growth %	10.99	3.63	-3.28	5.96	-11.64
Tangible Book Value, 1 Yr. Growth %	9.19	-0.07	-0.48	-2.12	-8.02
Common Equity, 1 Yr. Growth %	12.06	11.19	-4.83	10.43	-22.31
Cash From Operations, 1 Yr. Growth %	-11.99	-8.66	29.44	0.99	-12.28
Capital Expenditures, 1 Yr. Growth %	28.39	31.41	3.16	15.71	2.61
Levered Free Cash Flow, 1 Yr. Growth %	-39.48	60.5	-17.27	2.11	14.8
Unlevered Free Cash Flow, 1 Yr. Growth %	-38.89	60.3	-13.83	2.29	14.3
Dividend Per Share, 1 Yr. Growth %	5.25	-4.29	2.52	4.99	10.49
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.45	8.83	6.61	0.57	-1.15
Gross Profit, 2 Yr. CAGR %	-1.53	4.71	6.53	6.42	2.65
EBITDA, 2 Yr. CAGR %	-4.96	-1.6	-1.44	4.54	2.02
EBITA, 2 Yr. CAGR %	-1.16	3.19	2.42	8.91	4.67
EBIT, 2 Yr. CAGR %	-1.42	1.94	2.21	8.74	4.49
Earnings From Cont. Operations, 2 Yr. CAGR %	4.82	16.69	3.85	-12.24	-3.25
Net Income, 2 Yr. CAGR %	3.7	17.02	3.56	-13.3	20.82
Normalized Net Income, 2 Yr. CAGR %	-1.1	0.99	-0.01	9.52	5.73
Diluted EPS Before Extra, 2 Yr. CAGR %	4.12	18.76	5.04	-12.48	-1.51
Accounts Receivable, 2 Yr. CAGR %	-14.64	15.05	5.98	0.73	4.75
Inventory, 2 Yr. CAGR %	6.05	15.29	4.55	-6.57	-11.13
Net Property, Plant and Equip., 2 Yr. CAGR %	-7.38	1	1.72	4.09	-8.36
Total Assets, 2 Yr. CAGR %	7.65	7.25	0.11	1.23	-3.24
Tangible Book Value, 2 Yr. CAGR %	9.75	4.46	-0.28	-1.31	-5.12
Common Equity, 2 Yr. CAGR %	13.88	11.62	2.87	2.52	-7.38
Cash From Operations, 2 Yr. CAGR %	-0.85	-10.34	8.74	14.33	-5.88
Capital Expenditures, 2 Yr. CAGR %	-8.24	29.89	16.43	9.26	8.94
Levered Free Cash Flow, 2 Yr. CAGR %	-12.86	-1.18	13.25	-5.37	5.47
Unlevered Free Cash Flow, 2 Yr. CAGR %	-13.36	-0.86	15.66	-3.6	5.64
Dividend Per Share, 2 Yr. CAGR %	1.5	0.36	-0.8	3.74	1.36
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.95	4.94	5.52	5.03	-5.62
Gross Profit, 3 Yr. CAGR %	-0.14	1.84	4.53	7.25	-0.64
EBITDA, 3 Yr. CAGR %	-1.81	-2.49	-0.94	2.56	-1.16
EBITA, 3 Yr. CAGR %	1.27	0.16	2.61	5.39	2.22
EBIT, 3 Yr. CAGR %	1.09	-0.65	2.47	5.28	2.11
Earnings From Cont. Operations, 3 Yr. CAGR %	-12.22	11.12	5.54	-1.29	-9.09
Net Income, 3 Yr. CAGR %	-13.57	10.75	5.14	-1.71	7.41
Normalized Net Income, 3 Yr. CAGR %	1.5	-1.68	1.61	4.35	2.73
Diluted EPS Before Extra, 3 Yr. CAGR %	-12.64	11.79	6.49	-0.43	-11.87
Accounts Receivable, 3 Yr. CAGR %	-6.27	-2.59	5.43	8.78	2.21
Inventory, 3 Yr. CAGR %	2.88	12.51	4.69	3.4	-11.99
Net Property, Plant and Equip., 3 Yr. CAGR %	-5.05	-3.71	0.47	4.09	-5.84
Total Assets, 3 Yr. CAGR %	7.11	6.29	3.62	2.02	-3.25
Tangible Book Value, 3 Yr. CAGR %	5.89	6.37	2.78	-0.9	-3.6
Common Equity, 3 Yr. CAGR %	14.5	12.97	5.84	5.33	-6.54
Cash From Operations, 3 Yr. CAGR %	2.89	-3.52	1.34	6.09	4.67
Capital Expenditures, 3 Yr. CAGR %	-5.88	3.43	20.29	16.19	-0.9
Levered Free Cash Flow, 3 Yr. CAGR %	-20.02	6.94	-8.08	11.15	-4.07
Unlevered Free Cash Flow, 3 Yr. CAGR %	-19.62	6.49	-6.5	12.61	-2.89
Dividend Per Share, 3 Yr. CAGR %	4.98	-0.47	1.17	0.99	1.85
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.1	2.26	3.17	3.17	-0.09
Gross Profit, 5 Yr. CAGR %	-0.27	0.79	2.47	3.65	1.47
EBITDA, 5 Yr. CAGR %	3.19	0.13	-0.5	0.66	-0.94
EBITA, 5 Yr. CAGR %	3.86	1.16	1.62	2.61	1.66
EBIT, 5 Yr. CAGR %	4.57	0.67	1.54	2.55	1.59
Earnings From Cont. Operations, 5 Yr. CAGR %	3.6	5.07	-6.11	1.11	0.46
Net Income, 5 Yr. CAGR %	3.13	4.88	-7.09	0.42	11.15
Normalized Net Income, 5 Yr. CAGR %	4.68	0.14	0.89	2.13	1.51
Diluted EPS Before Extra, 5 Yr. CAGR %	4.98	6.92	-5.96	1.36	-0.7
Accounts Receivable, 5 Yr. CAGR %	1.48	-2.73	-1.55	-1.27	7.16
Inventory, 5 Yr. CAGR %	1.83	8.4	3.54	4.45	-1.95
Net Property, Plant and Equip., 5 Yr. CAGR %	-2.38	-2.57	-2.4	-0.66	-3.16
Total Assets, 5 Yr. CAGR %	5.88	4.63	4.25	4.24	0.82
Tangible Book Value, 5 Yr. CAGR %	14.16	7.49	3.38	3.23	-0.45
Common Equity, 5 Yr. CAGR %	0.9	7.19	9.7	8.67	0.34
Cash From Operations, 5 Yr. CAGR %	2.5	-1.56	5.19	3.26	-1.61
Capital Expenditures, 5 Yr. CAGR %	-9.29	-0.71	2.48	5.72	10.43
Levered Free Cash Flow, 5 Yr. CAGR %	3.7	19.63	-8.1	0.82	-3.9
Unlevered Free Cash Flow, 5 Yr. CAGR %	3.19	17.94	-7.03	1.4	-2.97
Dividend Per Share, 5 Yr. CAGR %	6.4	5.53	2.63	1.19	1.25